期刊文献+

病情积分法^(131)I治疗甲亢 被引量:2

Integration of Illness For ^(131)I Treatment of Hyperthyroidism
下载PDF
导出
摘要 目的:探讨一种科学性、操作性强,可具体量化,符合个性化原则的甲亢131I治疗量的计算方法,以提高甲亢的治愈率,降低甲减的发生率。方法以:传统给药法组204例,和病情积分法96例,傅统给药法采取每克甲状腺组织平均投131I量为2545KBq(68.8KBq~3367KBq),每位对象一次服131I量为203.87MBq(62.9MBq~444MBq)。病情积分法组96例,采用以100分为基础,综合患者年龄、心率、前期治疗情况、甲状腺摄131I高峰出现时间、血清FT3、FT4、TSH、TGA、TMA含量等情况进行分数加减的“病情积分法”,计算出最后的积分数即为每克甲状腺组织的131I给予量(μCi);病情积分法平均每克甲状腺组织投131I量为4070KBq(2960KBq~7030KBq),每位病人一次服131I量平均321.16MBq(133.2~1221MBq)。结果:病情积分法治疗甲亢,一次治愈率为88.5%,比传统给药法提高了16%;早期甲减的发生率为4.2%,比传统给药法降低了0.2%。结论:该研究设计科学、合理,可操作性强,可具体量化,符合个性化原则,可明显提高甲亢的一次治愈率。 Objective:To approach into a scientific and feasible calculation of therapeutic dosage of 131 I in order to improve the cure rate of hyperthyroidism and reduce the incidence of hypothyroidism.Methods:The patients were divided into 2 groups,the first group (204 patients) were treated by conventional administration and the second group (96 patients) by integration of illness.The conventional administration included 131 I 2545 KBq (68.08 KBq^3367 KBq)in average given to one gram of thyroid tissue and 203.87 MBq (62.9 MBq^44 MBq) taken by one patient each time.On the basis of 100,integrating the age ,heart rate,previous treatment, the peak time during uptake of 131 I by thyroid and the contents of FT 3,FT 4 and TSH in sera,'the integration of illness' was worked out ,and the last integral number calcalated is the given amount of 131 I(μGi) to one gram of thyroid tissue.In the integration of illness,4070 KBq(2 960 KBq^7 030 KBq) of 131 I was given to each gram thyroid tissue and each patient took 131 I 321.16 Bq(133.2~1 221 MBq) in average each time.Results:With this treatment for hyperthyroidism,the cure rate on its first time was 88.55%,16% over conventional method of administration.Incidence of the early stage hypothyroidism was 4.2%,0.2% below that of conventional administration.Conclusion:This study is scientific,reasonable and feasible specially guantitative and in accordance with principles of characterization.It may notably improve one time cure rate of hyperthyroidism and reduce the incidence of hypothyroidism.
出处 《江西医学院学报》 1999年第4期43-46,共4页 Acta Academiae Medicinae Jiangxi
基金 江西省卫生厅资助
关键词 碘放射性同位素 甲状腺功能亢进 病情积分 病因学 radioiodineisotope hyperthyroidism integration of illness etiology
  • 相关文献

参考文献1

共引文献29

同被引文献26

  • 1李河峰.碘治疗Crare's病后甲减替代治疗的评估.衡阳医学院学报,2000,28(1):24-25.
  • 2Shulinan DI, MUHAR, I, Jorgensen EV, et al. Clinical features of patients with Graves disease undergoing remission after antithyroid drug treatnent,Thyroid, 1997,7:369-375.
  • 3Niccoli P, Vitti P, Rago T, et al. Srigical treatment of Graves disease; subtotal or tetal thyroidectomy.Surgery, 1996,120:1020-1024.
  • 4Moll Jr GW, patel BR. Pediatric Grave disease,theapeutic options and experience with radioiodine at the University of Mississippi Medical Center.South Med J, 1997,90:1017-1022.
  • 5Tuttle RM, Patience T, Budd S, Treatrrent woth propylthiouracil before radio active iodine therapt is asscciated woth a higher treatment failure rate than therapy with radioactive iodine aline in Graves disease, Thyreid, 1995,5:243-247.
  • 6Sabri O, Zimmy M, Schulx G, et al. Success rate of mdioiodine therapy in Graves disease; the influence of thyrostatic medicatiom J Clin Endccrinol Metab, 1999,84:1229-1233.
  • 7Nidiferov Y, Gnepp DR, Fagin JA, Thyroid lesions in children and adoiesce nts after the Chenobyl disater, imphcauons tor the study of radiation turnemgenesis.J Clin Endoermel Metab, 1996,81:9-14.
  • 8邢家骧.131碘治疗甲状腺疾病[M].人民出版社,2002.265-268.
  • 9Rivkees SA, Sklar C, Freemak M, The managementof Graves′ diseaes in children, with special emphasison radioiodine trealment [J] Clin Endcrinol Metab,1998,11(86):3766-3766.
  • 10Vitip, Rago T, Chievati L, et al Clinical feahure at diagnosis and responses to medieal therapy[1]. Thyroid, 1997,7:369-375.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部